New biosimilar aims to match leading melanoma drug in major trial

NCT ID NCT07221734

First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 35 times

Summary

This study tests whether MB11, a biosimilar (a nearly identical copy) of the cancer drug Opdivo, works as well and is as safe as the original drug. About 632 adults with advanced melanoma that has not been treated before will receive either MB11 or Opdivo. The goal is to see if the biosimilar can control the disease similarly, potentially offering a more affordable treatment option.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED (UNRESECTABLE OR METASTATIC) MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site 111003

    RECRUITING

    Funchal, Portugal

  • Site 117002

    RECRUITING

    Kyiv, Ukraine

  • Site 117003

    RECRUITING

    Ternopil, Ukraine

  • Site 117004

    RECRUITING

    Uzhhorod, Ukraine

  • Site 117005

    RECRUITING

    Ivano-Frankivsk, Ukraine

  • Site 117006

    RECRUITING

    Kyiv, Ukraine

  • Site 117007

    RECRUITING

    Kyiv, Ukraine

  • Site 117010

    RECRUITING

    Uzhhorod, Ukraine

  • Site 117012

    RECRUITING

    Kyiv, Ukraine

  • Site 117013

    RECRUITING

    Kyiv, Ukraine

  • Site 117014

    RECRUITING

    Kyiv, Ukraine

  • Site 117015

    RECRUITING

    Chernivtsi, Ukraine

  • Site 117016

    RECRUITING

    Kyiv, Ukraine

  • Site 117017

    RECRUITING

    Kyiv, Ukraine

  • Site 117018

    RECRUITING

    Kyiv, Ukraine

  • Site 117019

    RECRUITING

    Uzhhorod, Ukraine

  • Site 117020

    RECRUITING

    Kyiv, Ukraine

  • Site 117021

    RECRUITING

    Kyiv, Ukraine

  • Site 117022

    RECRUITING

    Lutsk, Ukraine

Conditions

Explore the condition pages connected to this study.